177 related articles for article (PubMed ID: 14965240)
1. 5-HT1 receptors.
Lanfumey L; Hamon M
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):1-10. PubMed ID: 14965240
[TBL] [Abstract][Full Text] [Related]
2. 5-HT5 receptors.
Nelson DL
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):53-8. PubMed ID: 14965244
[TBL] [Abstract][Full Text] [Related]
3. Decreased G-protein coupling of serotonin 5-HT(1A) receptors in the brain of 5-HT(1B) knockout mouse.
Ase AR; Sénécal J; Reader TA; Hen R; Descarries L
Neuropharmacology; 2002 Jun; 42(7):941-9. PubMed ID: 12069904
[TBL] [Abstract][Full Text] [Related]
4. 5-HT2 receptors.
Leysen JE
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):11-26. PubMed ID: 14965241
[TBL] [Abstract][Full Text] [Related]
5. 5-HT7 receptors.
Thomas DR; Hagan JJ
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):81-90. PubMed ID: 14965246
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a 5-HT1-type serotonin receptor in the red flour beetle, Tribolium castaneum.
Vleugels R; Lenaerts C; Baumann A; Vanden Broeck J; Verlinden H
PLoS One; 2013; 8(5):e65052. PubMed ID: 23741451
[TBL] [Abstract][Full Text] [Related]
7. Inverse agonist and neutral antagonist actions of synthetic compounds at an insect 5-HT1 receptor.
Troppmann B; Balfanz S; Baumann A; Blenau W
Br J Pharmacol; 2010 Apr; 159(7):1450-62. PubMed ID: 20233210
[TBL] [Abstract][Full Text] [Related]
8. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
[TBL] [Abstract][Full Text] [Related]
9. 5-ht6 receptors.
Woolley ML; Marsden CA; Fone KC
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):59-79. PubMed ID: 14965245
[TBL] [Abstract][Full Text] [Related]
10. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
11. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
[TBL] [Abstract][Full Text] [Related]
12. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
Slassi A
Curr Top Med Chem; 2002 Jun; 2(6):559-74. PubMed ID: 12052194
[TBL] [Abstract][Full Text] [Related]
14. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
[TBL] [Abstract][Full Text] [Related]
15. Ligands for the investigation of 5-HT autoreceptor function.
Roberts C; Price GW; Middlemiss DN
Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
McCreary AC; Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
[TBL] [Abstract][Full Text] [Related]
17. 5-HT4 receptors.
Bockaert J; Claeysen S; Compan V; Dumuis A
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):39-51. PubMed ID: 14965243
[TBL] [Abstract][Full Text] [Related]
18. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
19. 5-HT 1B/D receptor antagonists.
Pauwels PJ
Gen Pharmacol; 1997 Sep; 29(3):293-303. PubMed ID: 9378233
[TBL] [Abstract][Full Text] [Related]
20. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships.
Klein MT; Dukat M; Glennon RA; Teitler M
J Pharmacol Exp Ther; 2011 Jun; 337(3):860-7. PubMed ID: 21422162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
